The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) brings together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology.
SEDRIC aims to transform the way countries are able to track, share and analyse information about the rise and spread of drug-resistant infections.
Better information will speed up action and improve public health interventions, saving many lives in the process.
SEDRIC will:
It began its work in January 2018 and is funded by Wellcome.
Professor Sharon Peacock, the board's chair, explains more about what SEDRIC aims to do.
Would you like to help shape SEDRIC’s work and be part of a global community of experts?
Applications are open to anyone who has an interest in surveillance and epidemiology of drug-resistant infections.
Read more about eligibility and apply on the SEDRIC website.
SEDRIC: supporting the transition from strategy to action
Read our open letter on SEDRIC’s key role in transforming the ways that the global community are able to track, share and analyse information on antibiotic use.
Why global intelligence on superbugs is vital to stop antibiotic resistance
Read Professor Sharon Peacock's article, and watch an explanatory short film.
The collective overuse of antibiotics has caused one of the most urgent health problems. We want to transform the world's response towards stemming the rise of drug-resistant infections.
This Q&A explains what drug-resistant infections are, who is affected and what we can do to stem them.
Read more articles about drug-resistant infections.
